11 - 20 out of 34Page size: 10
  1. 2021

  2. Changes in Gene Expression and Neuroinflammation in the Hippocampus after Focal Brain Ischemia: Involvement in the Long-Term Cognitive and Mental Disorders

    Shishkina, G. T., Kalinina, T. S., Gulyaeva, N. V., Lanshakov, D. A. & Dygalo, N. N., Jun 2021, In: Biochemistry (Moscow). 86, 6, p. 657-666 10 p., 3.

    Research output: Contribution to journal › Review article › peer-review

  3. Single neonatal dexamethasone administration has long-lasting outcome on depressive-like behaviour, Bdnf, Nt-3, p75ngfr and sorting receptors (SorCS1-3) stress reactive expression

    Lanshakov, D. A., Sukhareva, E. V., Bulygina, V. V., Bannova, A. V., Shaburova, E. V. & Kalinina, T. S., 14 Apr 2021, In: Scientific Reports. 11, 1, 13 p., 8092.

    Research output: Contribution to journal › Article › peer-review

  4. 2020

  5. Chemogenetic Activation of Glutamatergic Neurons in the Juvenile Rat Cortex Reduces Anxiety

    Dygalo, N. N., Lanshakov, D. A., Komysheva, N. P., Drozd, U. S., Shaburova, E. V., Sukhareva, E. V. & Shishkina, G. T., 1 Jan 2020, In: Doklady Biochemistry and Biophysics. 490, 1, p. 16-18 3 p., 5.

    Research output: Contribution to journal › Article › peer-review

  6. Эффективная трансдукция нейронов головного мозга лентивирусными векторами, очищенными ионообменной хроматографией

    Shaburova, E. V. & Lanshakov, D. A., 2020, In: Biotekhnologiya. 36, 5, p. 89-97 9 p., 10.

    Research output: Contribution to journal › Article › peer-review

  7. 2019

  8. Extrahypothalamic CRH and its receptors change tyrosine hydroxylase expression after neonatal dexamethasone treatment

    Sukhareva, E. V., Lanshakov, D., Kalinina, T., Bulygina, V. & Dygalo, N., Dec 2019, In: European Neuropsychopharmacology. 29, p. S301-S302 2 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  9. Long-term up-regulation of tyrosine hydroxylase gene expression after neonatal dexamethasone

    Kalinina, T., Sukhareva, E., Bulygina, V., Lanshakov, D., Egorova, K. & Dygalo, N., Dec 2019, In: European Neuropsychopharmacology. 29, p. S166-S167 6 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  10. Subanesthetic dose of ketamine relieves depression-like behavior induced by optogenetic stimulation of the hippocampal pyramidal neurons

    Dygalo, N., Drozd, U. S., Kalinina, T. S., Sukhareva, E. V., Bulygina, V. V., Shishkina, G. T. & Lanshakov, D. A., Dec 2019, In: European Neuropsychopharmacology. 29, p. S94-S94 1 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  11. Expression of Neurotrophic Factor 3 in the Hippocampus of Neonatal Rats after Administration of Dexamethasone

    Bulygina, V. V., Kalinina, T. S., Lanshakov, D. A. & Dygalo, N. N., Oct 2019, In: Neurochemical Journal. 13, 4, p. 349-354 6 p.

    Research output: Contribution to journal › Article › peer-review

  12. Ketamine improves depressive symptoms caused by stress and induces c-Fos expression in the brain resembling some effects of stress

    Dygalo, N., Drozd, U. S., Kalinina, T. S., Sukhareva, E. V., Bulygina, V. V., Shishkina, G. T. & Lanshakov, D. A., 2019, In: European Neuropsychopharmacology. 29, p. S212-S212 1 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  13. TpH2 expression after neonatal dexamethasone treatment and acute or chronic stress in adulthood

    Kalinina, T., Sukhareva, E., Lanshakov, D., Bulygina, V. & Dygalo, N., 2019, In: European Neuropsychopharmacology. 29, p. S222-S222 1 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

Previous 1 2 3 4 Next

ID: 19277923